CIO Review Selects Indegene for 20 Most Promising Pharma and Life Sciences Technology Solution Providers 2015

Annual list showcases the 20 Most Promising Pharma and Life Sciences Technology Solution Providers 2015. Indegene makes it to CIO Review’s top list for Pharma and Life Sciences Technology Solution Providers for its clinical, commercial, and marketing solutions to global life science and healthcare organizations.

FREMONT, CA—March 31, 2015—CIO Review (cioreview.com) has chosen Indegene (indegene.com) for its 20 Most Promising Pharma and Life Sciences Technology Solution Providers 2015. The positioning is based on Indegene's solutions that integrate technology, medical science, and communication expertise.

The annual list of companies is selected by a panel of experts and members of CIO Review’s editorial board to recognize and promote technology entrepreneurship. “Indegene has been on our radar for some time for stirring a revolution in the Pharma and Life Sciences technology space, and we are happy to showcase them this year due to their continuing excellence in delivering top-notch Pharma and Life Sciences solutions,” said Harvi Sachar, Publisher and Founder, CIOReview. “Indegene solutions continued to break new ground within the past year, benefiting its customers around the globe, and we’re excited to have them featured on our top companies list.”

“Indegene is honored to be recognized by CIO Review’s panel of experts and thought leaders,” said Manish Gupta, CEO, Indegene.

About Indegene

Indegene partners with clients across the entire life science value chain to drive both productivity and revenue by delivering better patient outcomes; optimizing cost; enhancing regulatory agility and improving sales and marketing effectiveness.

About CIO Review

CIO Review constantly endeavors to identify “The Best” in a variety of areas important to tech business. Through nominations and consultations with industry leaders, our editors choose the best in different domains. Pharma and Life Sciences Technology Special Edition is an annual listing of 20 Most Promising Pharma and Life Sciences Technology Solution Providers in the U.S.